The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.50
Bid: 486.00
Ask: 491.00
Change: 0.50 (0.10%)
Spread: 5.00 (1.029%)
Open: 487.00
High: 488.50
Low: 487.00
Prev. Close: 488.00
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results and Investor Presentation

30 Aug 2023 07:00

RNS Number : 7181K
Oakley Capital Investments Limited
30 August 2023
 

30 August 2023

 

Oakley Capital Investments Limited

Notice of Results and Investor Presentation

 

Oakley Capital Investments Limited ("OCI")1, a listed investment company that invests in the funds managed by Oakley Capital ("Oakley")2, will announce its results for the 6-months ended 30 June 2023 on Thursday 14 September 2023.

A live presentation of the results, delivered by Oakley Partner Steven Tredget, will be broadcast online at 09:00 GMT on the day.

To register your attendance at this event, please use the following link https://www.investis-live.com/oakley-capital/64dc97390120c60d0008b333/gdrt

A recording of the webcast presentation will also be available on the OCI website shortly after the event.

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Chris Clarke / Darren Vickers / Owen Matthews

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

2 Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V and Oakley Capital Origin Fund and are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

For more information on the Oakley Fund strategies in which OCI invests, please click here.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORNKCBBFBKDNFB
Date   Source Headline
27th May 20207:00 amRNSResult of Annual General Meeting
22nd May 20204:33 pmRNSTime Out equity fundraise and OCI loan repayment
19th May 20207:00 amRNSDirector Declaration
7th May 20207:00 amRNSDirectorate Change and Total Voting Rights
1st May 20207:00 amRNSNotice of Annual General Meeting
8th Apr 20207:00 amRNSOakley completes sale of investment in Inspired
25th Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20207:00 amRNSAnnual Report and Accounts 2019
18th Mar 20204:22 pmRNSTransaction in own Shares
18th Mar 20207:00 amRNSShare Buy-Back
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20207:33 amRNSResults analysis from Kepler Trust Intelligence
12th Mar 20207:00 amRNSFinal Annual Results 2019
4th Mar 20207:00 amRNSAcquisition of Globe-Trotter
24th Feb 20207:00 amRNSOakley agrees sale of atHome
30th Jan 20207:00 amRNSDirector Dealing
29th Jan 20207:00 amRNSTrading update for the year ended 31 December 2019
24th Dec 20199:00 amRNSUpdate on Rastreator and Acierto
23rd Dec 20193:06 pmRNSHolding(s) in Company
20th Dec 20194:52 pmRNSDirector/PDMR Shareholding
20th Dec 20193:42 pmRNSTransaction in Own Shares
20th Dec 20192:27 pmRNSShare Buy-Back
16th Dec 20197:00 amRNSAppointment of Non-Executive Director
12th Dec 20197:00 amRNSOakley agrees sale of WebPros to CVC
3rd Dec 20197:00 amRNSHolding(s) in Company
15th Nov 20197:00 amRNSDirector Dealing
15th Nov 20197:00 amRNSDirector Dealing
14th Nov 20193:45 pmRNSTransaction in Own Shares
14th Nov 20197:00 amRNSShare Buy-back
18th Oct 20194:58 pmRNSHolding(s) in Company
13th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSResults for the six months ended 30 June 19
29th Aug 20197:00 amRNSInvestment in leading design company Alessi
23rd Aug 20198:00 amRNSAdmission to the Specialist Fund Segment
23rd Aug 20197:00 amRNSResult of Annual General Meeting
20th Aug 20195:30 pmRNSOakley Capital Investments
15th Aug 20197:00 amRNSAcquisition of Seven Miles
26th Jul 20197:00 amRNSNotice of AGM
24th Jul 20197:00 amRNSTrading update for the six months ended 30 June 19
18th Jul 20196:11 pmRNSPublication of Prospectus
18th Jul 20197:01 amRNSProposed move to SFS & AIM cancellation
18th Jul 20197:00 amRNSDirectorate Change
20th Jun 201912:50 pmRNSAnnual Report and Accounts and Shares in Issue
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.